Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

20.79
+1.608.34%
Post-market: 20.880.0881+0.42%19:59 EDT
Volume:3.23M
Turnover:66.24M
Market Cap:15.34B
PE:-67.06
High:21.30
Open:19.49
Low:19.20
Close:19.19
Loading ...

Stock Track | Summit Therapeutics Soars 6.69% Pre-market on Clinical Trial Collaboration with Pfizer

Stock Track
·
24 Feb

Earnings Flash (SMMT) Summit Therapeutics Posts Q4 Total Operating Expenses of $65.8M

MT Newswires Live
·
24 Feb

Summit Therapeutics Q4 2024 Adj EPS $(0.07) Beats $(0.08) Estimate

Benzinga
·
24 Feb

BRIEF-Summit Therapeutics Q4 Net Income USD -61.2 Million

Reuters
·
24 Feb

Summit Therapeutics Q4 Net Income USD -61.2 Million

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Q4 Operating Expenses USD 65.8 Million

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Q4 Operating Income USD -65.6 Million

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024

Business Wire
·
24 Feb

Summit Therapeutics Inc - Clinical Trials Expected to Start Mid-Year

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Announces Clinical Trial Collaboration With Pfizer to Evaluate Ivonescimab in Combination With Pfizer Antibody Drug Conjugates (Adcs)

THOMSON REUTERS
·
24 Feb

Summit Therapeutics - Under Terms of Agreement, Co to Provide Ivonescimab, Pfizer to Conduct Study Operations

THOMSON REUTERS
·
24 Feb

Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

Business Wire
·
24 Feb

Insider Stock Buying Reaches US$78.8m On Summit Therapeutics

Simply Wall St.
·
23 Feb

Press Release: Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025

Dow Jones
·
18 Feb

Summit Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
14 Feb

Why Summit Therapeutics Inc. (SMMT) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey
·
08 Feb